Intra-cellular therapies, inc. (ITCI)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash flows used in operating activities
Net loss

-47,410

-40,582

-34,862

-37,441

-34,835

-40,748

-41,522

-37,376

-35,480

-30,208

-22,870

-17,760

-26,933

-27,485

-30,265

-30,834

-27,841

-28,834

-32,160

-21,511

-22,286

-15,199

-6,415

-4,533

-4,543

-8,040

-13,178

-10

-5,638

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

148

141

129

105

101

95

94

95

82

58

53

51

50

50

50

48

47

47

45

31

15

6

6

6

6

7

4

4

6

Share-based compensation

5,504

5,939

4,806

4,987

5,055

4,424

4,373

4,310

4,287

3,610

2,500

4,369

4,160

3,725

3,686

3,696

3,592

3,424

2,865

2,500

2,099

1,651

1,702

290

199

108

119

89

74

Stock issued for services

53

48

48

48

48

48

48

47

47

47

47

47

47

62

62

62

45

45

45

45

45

-

-

-

-

-

-

-

-

Amortization of premiums and discounts on investment securities, net

298

260

224

289

356

398

310

177

56

-28

-86

-172

-141

-124

-101

-136

-182

-192

-175

-193

-151

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable, net

1,351

-

-

-

-

-

-

-

-

-6

-55

-6

-26

93

-96

98

-30

30

-9

5

-48

-72

-94

51

-168

85

-24

45

-69

Inventory

1,391

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

1,562

2,555

717

-5,263

526

642

1,368

-249

1,265

-423

-837

2,383

-243

-18

3

-2,766

-1,235

6,492

-7,078

7,345

-21

-85

881

-221

-108

-43

703

-44

-41

Long term deferred tax asset, net

-264

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Professional fees paid by related party on behalf of the Company

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

-

Accounts payable

3,569

1,194

598

-2,941

-5,386

3,507

5,074

-4,659

3,865

1,765

2,632

-5,382

3,403

-1,662

1,527

1,930

326

927

-4,206

336

2,521

1,548

88

-1,726

-1,252

-632

620

2

3,362

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

2,269

-3,984

2,367

-

-5,219

8,504

2,356

-

5,274

-5,611

1,514

-

750

554

-1,670

-

-127

2,316

209

Accrued liabilities and other

-8,740

-

232

2,959

270

-

5,236

3,931

1,519

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liabilities, net

-12

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-416

-416

-416

-416

Deferred rent

-

-

-

-

-

323

-35

-35

15

-24

-24

-24

93

304

304

288

373

715

360

360

160

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-16,398

-

-29,657

-13,499

-19,650

-35,055

-20,510

-31,004

-15,709

-6,206

-4,420

-5,197

-6,982

-8,627

-4,763

-6,909

-2,291

Net cash used in operating activities

-51,226

-35,055

-29,989

-27,308

-35,629

-29,161

-28,409

-33,614

-26,983

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9

-

Cash flows (used in) provided by investing activities
Purchases of investments

210,466

22,387

32,555

11,450

14,327

30,042

57,457

91,786

91,870

246,252

68,640

104,089

101,944

75,658

137,869

149,584

32,644

283,161

137,475

22,528

71,142

-

-

-

-

-

-

-

-

Maturities of investments

57,503

59,474

73,012

67,234

59,136

44,247

85,737

120,761

155,442

94,883

105,906

135,038

93,103

77,335

190,848

177,668

42,216

32,261

92,000

24,169

4,958

-

-

-

-

0

0

-41

1,541

Purchases of property and equipment

22

-650

221

1,062

67

58

16

21

295

516

104

74

28

-0

9

35

3

37

108

194

520

3

-0

5

3

0

24

3

5

Net cash (used in) provided by investing activities

-152,984

37,737

40,236

54,721

44,741

14,146

28,264

28,953

63,277

-151,884

37,162

30,873

-8,869

1,677

52,970

28,047

9,568

-250,937

-45,583

1,446

-66,704

-1,447

-17,833

-47,449

-3

0

-24

-45

1,536

Cash flows provided by financing activities
Proceeds from exercise of stock options

589

2,792

152

259

31

185

144

6

337

54

0

6

224

27

102

184

163

335

57

159

101

-

-

-

-

-

-

-

-

Increase in note payable - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

-

Proceeds of public offering, net

276,978

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

327,913

0

122,083

0

0

0

116,191

-

-

0

-

Payment of costs of public offerings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11

466

-14

293

0

0

10

738

-

-

-

-

Net cash provided by financing activities

277,567

2,792

152

259

31

185

155

6

337

162,126

0

6

224

-124,972

125,102

184

163

324

327,504

174

121,890

63

29

169

115,453

-

-

5

-

Net increase in cash, cash equivalents, and restricted cash

73,356

5,473

10,399

27,672

9,143

-14,829

9

-4,654

36,631

-14,550

22,750

5,992

-25,043

-151,745

148,415

14,732

-9,918

-285,668

261,410

-29,383

39,477

-7,590

-22,224

-52,478

108,467

-8,921

29,184

-4

-754

Non-cash investing and financing activities
Right of use assets under operating leases

97

-

-

-

219

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

2

5

-

-

-

-

Cash paid for taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

23

3

-

6

6

0

Professional fees paid by related party on behalf of the Company

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

-